NASDAQ
AdaptHealth Corp. (AHCO) has a consensus Buy rating from 12 analysts with an average price target of $14.40, representing +39.9% upside from the current price of $10.29.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| May 11, 2026 | Unknown | RBC Capital | $15.00 | $11.53 | +30.15% |
| May 6, 2026 | Unknown | Canaccord Genuity | $16.00 | $11.75 | +36.17% |
| May 6, 2026 | Eric Coldwell | Robert W. Baird | $18.00 | $11.75 | +53.19% |
| Apr 20, 2026 | Brian Tanquilut | Jefferies | $11.00 | $12.73 |
May 11, 2026 | Maintained | RBC Capital | Outperform | Outperform |
May 6, 2026 | Maintained | Canaccord Genuity | Buy | Buy |
May 6, 2026 | Maintained | UBS | Buy | Buy |
Apr 13, 2026 | Maintained | Truist Securities | Buy | Buy |
Feb 26, 2026 | Maintained | Leerink Partners | Outperform | Outperform |
| -13.56% |
| Feb 26, 2026 | Whit Mayo | Leerink Partners | $12.00 | $9.33 | +28.62% |
No price data available for this timeframe.